Utah Medical Products (NASDAQ:UTMD) Stock Rating Lowered by StockNews.com

Utah Medical Products (NASDAQ:UTMDGet Free Report) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Thursday.

Separately, TheStreet lowered shares of Utah Medical Products from a “b-” rating to a “c+” rating in a research report on Monday, February 12th.

Get Our Latest Analysis on UTMD

Utah Medical Products Stock Down 0.7 %

Shares of NASDAQ:UTMD opened at $69.31 on Thursday. The company has a market cap of $251.60 million, a P/E ratio of 15.17 and a beta of 0.12. The business has a fifty day simple moving average of $76.82 and a 200-day simple moving average of $81.93. Utah Medical Products has a 52 week low of $69.00 and a 52 week high of $100.59.

Utah Medical Products (NASDAQ:UTMDGet Free Report) last issued its quarterly earnings results on Tuesday, January 30th. The medical instruments supplier reported $1.18 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 13.73% and a net margin of 33.12%. The firm had revenue of $12.33 million for the quarter.

Hedge Funds Weigh In On Utah Medical Products

A number of large investors have recently modified their holdings of UTMD. Penn Mutual Asset Management LLC increased its position in Utah Medical Products by 46.3% during the 4th quarter. Penn Mutual Asset Management LLC now owns 53,093 shares of the medical instruments supplier’s stock worth $4,471,000 after purchasing an additional 16,810 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Utah Medical Products by 16.9% in the first quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical instruments supplier’s stock worth $9,145,000 after acquiring an additional 14,693 shares in the last quarter. Ancora Advisors LLC raised its stake in shares of Utah Medical Products by 51.1% in the 1st quarter. Ancora Advisors LLC now owns 40,338 shares of the medical instruments supplier’s stock valued at $3,494,000 after acquiring an additional 13,649 shares during the period. LSV Asset Management acquired a new position in shares of Utah Medical Products during the 1st quarter valued at $1,177,000. Finally, Natixis Advisors L.P. purchased a new stake in Utah Medical Products during the 3rd quarter worth $1,102,000. 70.35% of the stock is currently owned by hedge funds and other institutional investors.

About Utah Medical Products

(Get Free Report)

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

See Also

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.